Recent advances in image-guided targeted prostate biopsy

Abdominal Imaging

Volumn 40, Issue 6, 2015, Pages 1788-1799

  Brown, Anna M ^a,b   Elbuluk, Osama ^a,c   Mertan, Francesca ^a,d   Sankineni, Sandeep ^a   Margolis, Daniel J ^c   Wood, Bradford J ^a   Pinto, Peter A ^a   Choyke, Peter L ^a   Turkbey, Baris ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GROVE CITY COLLEGE   (United States)

Author keywords

Biopsy; MRI; Prostate cancer; Targeted; TRUS

Indexed keywords

AFTERIMAGE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; GLOBAL POSITIONING SYSTEM; HUMAN; IMAGE GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REAL TIME ECHOGRAPHY; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS;

HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84938997339     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-015-0353-8     Document Type: Review

References (66)

1. (2013) What are the key statistics about prostate cancer? www.cancer.org1
2. Sindhwani P, Wilson CM (2005) Prostatitis and serum prostate-specific antigen. Curr Prostate Rep 3:81–86. doi:10.1007/s11918-005-0020-6
3. Bouraoui Y, Ricote M, García-Tuñón I, et al. (2008) Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer. Cancer Detect Prev 32:23–32. doi:10.1016/j.cdp.2008.02.007
4. Lazzeri M, Abrate A, Lughezzani G, et al. (2014) Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination. Urology 83:606–612. doi:10.1016/j.urology.2013.10.016
5. Hedelin H, Johansson N, Ströberg P (2005) Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine. Scand J Urol Nephrol 39:154–159. doi:10.1080/00365590510007685
6. The website of the National Cancer Institute. http://www.cancer.gov.
7. Moyer VA (2012) Screening for prosate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 157:120–135
8. U.S. Preventive Services Task Force Screening for Prostate Cancer, Topic Page. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm.
9. Ilic D, Neuberger M, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev. doi:10.1002/14651858.CD004720.pub3
10. Vickers AJ, Thompson IM, Klein E, et al. (2014) A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology 83:592–596. doi:10.1016/j.urology.2013.09.075
11. Chiu PK-F, Teoh JY-C, Chan SY-S, et al. (2014) Role of PSA density in diagnosis of prostate cancer in obese men. Int Urol Nephrol 1–4:1–4. doi:10.1007/s11255-014-0826-7
12. Tormey WP (2014) The complexity of PSA interpretation in clinical practice. Surgeon 10–14:323–327. doi:10.1016/j.surge.2014.04.003
13. Blanchard P, Bakkour M, De Crevoisier R, et al. (2014) Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy. Urol Oncol 1–6. doi:10.1016/j.urolonc.2014.07.020
14. Anastasiadis E, van der Meulen J, Emberton M (2014) Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. doi:10.1111/iju.12634
15. Djavan B, Margreiter M (2007) Biopsy standards for detection of prostate cancer. World J Urol 25:11–17. doi:10.1007/s00345-007-0151-1
16. Pallwein L, Mitterberger M, Pelzer A, et al. (2008) Ultrasound of prostate cancer: recent advances. Eur Radiol 18:707–715. doi:10.1007/s00330-007-0779-7
17. Ellis WJ, Brawer MK (1995) Repeat prostate needle biopsy: who needs it? J Urol 153:1496–1498
18. Itatani R, Namimoto T, Atsuji S, et al. (2014) Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies. Eur J Radiol 83:1740–1745. doi:10.1016/j.ejrad.2014.06.026
19. Van den Bosch MR, Moman MR, van Vulpen M, et al. (2010) MRI-guided robotic system for transperineal prostate interventions: proof of principle. Phys Med Biol 55:N133–N140. doi:10.1088/0031-9155/55/5/N02
20. Anastasiadis AG, Lichy MP, Nagele U, et al. (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738–48; discussion 748–749. doi:10.1016/j.eururo.2006.03.007
21. Beyersdorff D, Winkel A, Hamm B, et al. (2005) Radiology MR imaging—guided prostate biopsy with a Closed MR Unit at 1. 5 T: Initial Results 1.
22. Pinto F, Totaro A, Calarco A, et al. (2011) Imaging in prostate cancer diagnosis: present role and future perspectives. Urol Int 86:373–382. doi:10.1159/000324515
23. Haffner J, Lemaitre L, Puech P, et al. (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108:E171–E178. doi:10.1111/j.1464-410X.2011.10112.x
24. Park BK, Park JW, Park SY, et al. (2011) Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol 197:W876–W881. doi:10.2214/AJR.11.6829
25. Labanaris a P, Engelhard K, Zugor V, et al. (2010) Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate. Prostate Cancer Prostatic Dis 13:65–70. doi:10.1038/pcan.2009.41
26. Siddiqui MM, Rais-Bahrami S, Truong H, et al. (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64:713–719. doi:10.1016/j.eururo.2013.05.059
27. Pinto PA, Chung PH, Rastinehad AR, et al. (2011) Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 186:1281–1285. doi:10.1016/j.juro.2011.05.078
28. Delongchamps NB, Peyromaure M, Schull A, et al. (2013) Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol 189:493–499. doi:10.1016/j.juro.2012.08.195
29. Puech P, Rouvière O, Renard-Penna R, et al. (2013) Prostate cancer diagnosis: multiparametric MR-targeted Biopsy with Cognitive and Transrectal US—MR fusion Guidance versus Systematic Biopsy—Prospective Multicenter Study. 268:461–469. doi:10.1148/radiol.13121501/-/DC1
30. Scherr D, Eastham J, Ohori M, Scardino P (2002) Prostate biopsy techniques and indications: when, where, and how? Semin Urol Oncol 20:18–31
31. Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71–74; discussion 74–75.
32. Babaian R, Toi A, Kamoi K, et al. (2000) A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 163:152–157
33. Jr PJ, O’Dowd G, Miller M, et al. (2003) Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169:125–129
34. Naughton C, Miller D, Yan Y (2001) Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores. J Urol 165:100–103. doi:10.1097/00005392-200101000-00025
35. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178:S14–S19. doi:10.1016/j.juro.2007.03.135
36. Taira A, Merrick GS, Galbreath RW, et al. (2010) Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 76:349–354. doi:10.1016/j.ijrobp.2009.02.021
37. Djavan B, Margreiter M (2007) Biopsy standards for detection of prostate cancer. World J Urol 25:11–17. doi:10.1007/s00345-007-0151-1
38. Durkan GC, Greene DR (2000) Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate. Prostate Cancer Prostatic Dis 3:13–20. doi:10.1038/sj.pcan.4500398
39. McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic carcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897–906
40. Robertson NL, Emberton M, Moore CM (2013) MRI-targeted prostate biopsy: a review of technique and results. Nat Rev Urol 10:589–597. doi:10.1038/nrurol.2013.196
41. Hoeks CMA, Schouten MG, Bomers JGR, et al. (2012) Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Eur Urol 62:902–909. doi:10.1016/j.eururo.2012.01.047
42. Roethke M, Anastasiadis AG, Lichy M, et al. (2012) MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 30:213–218. doi:10.1007/s00345-011-0675-2
43. Overduin CG, Fütterer JJ, Barentsz JO (2013) MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results. Curr Urol Rep 14:209–213. doi:10.1007/s11934-013-0323-z
44. Hong CW, Amalou H, Xu S, et al. (2014) Prostate biopsy for the interventional radiologist. J Vasc Interv Radiol 25:675–684. doi:10.1016/j.jvir.2013.12.568
45. Logan JK, Rais-Bahrami S, Turkbey B, et al. (2013) Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int. doi:10.1111/bju.12593
46. Sciarra A, Panebianco V, Ciccariello M, et al. (2010) Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy. Clin Cancer Res 16:1875–1883. doi:10.1158/1078-0432.CCR-09-2195
47. Kaplan I, Oldenburg NE, Meskell P, et al. (2002) Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging 20:295–299
48. Xu S, Kruecker J, Guion P, et al. (2007) Closed-loop control in fused MR-TRUS image-guided prostate biopsy. Med Image Comput Comput Assist Interv 10:128–135
49. Turkbey B, Xu S, Kruecker J, et al. (2011) Documenting the location of prostate biopsies with image fusion. BJU Int 107:53–57. doi:10.1111/j.1464-410X.2010.09483.x
50. Singh AK, Kruecker J, Xu S, et al. (2008) Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 101:841–845. doi:10.1111/j.1464-410X.2007.07348.x
51. Xu S, Kruecker J, Turkbey B, et al. (2008) Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 13:255–264. doi:10.3109/10929080802364645
52. Rastinehad AR, Turkbey B, Salami SS, et al. (2013) Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. J Urol 191:1749–1754. doi:10.1016/j.juro.2013.12.007
53. Vourganti S, Rastinehad A, Yerram NK, et al. (2012) Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 188:2152–2157. doi:10.1016/j.juro.2012.08.025
54. Marks L, Young S, Natarajan S (2013) MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 23:43–50. doi:10.1097/MOU.0b013e32835ad3ee
55. Wysock JS, Rosenkrantz AB, Huang WC, et al. (2013) A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of mr-targeted prostate biopsy: The PROFUS trial. Eur Urol 66:343–351. doi:10.1016/j.eururo.2013.10.048
56. Sonn GA, Natarajan S, Margolis DJ, et al. (2013) Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 189:86–91. doi:10.1016/j.juro.2012.08.095
57. Sonn GA, Chang E, Natarajan S, et al. (2014) Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 65:809–815. doi:10.1016/j.eururo.2013.03.025
58. Sonn GA, Filson CP, Chang E, et al. (2014) Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urol Oncol 1–6:952–957. doi:10.1016/j.urolonc.2014.04.003
59. Ukimura O, Desai MM, Palmer S, et al. (2012) 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 187:1080–1086. doi:10.1016/j.juro.2011.10.124
60. Cornud F, Brolis L, Delongchamps NB, et al. (2013) TRUS-MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer. Abdom Imaging 38:1447–1463. doi:10.1007/s00261-013-0018-4
61. Rud E, Baco E, Eggesbø HB (2012) MRI and ultrasound-guided prostate biopsy using soft image fusion. Anticancer Res 32:3383–3389
62. Mozer P, Rouprêt M, Le Cossec C, et al. (2014) First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer. BJU Int. doi:10.1111/bju.12690
63. Kuru TH, Roethke MC, Seidenader J, et al. (2013) Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 190:1380–1386. doi:10.1016/j.juro.2013.04.043
64. Radtke JP, Kuru TH, Boxler S, et al. (2014) Comparative analysis of transperineal template-saturation prostate biopsy versus MRI-targeted biopsy with MRI-US fusion-guidance. J Urol. doi:10.1016/j.juro.2014.07.098
65. Miyagawa T, Ishikawa S, Kimura T, et al. (2010) Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data. Int J Urol 17:855–860. doi:10.1111/j.1442-2042.2010.02612.x
66. Willis SR, Ahmed HU, Moore CM, et al. (2014) Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis. BMJ Open 4:e004895. doi:10.1136/bmjopen-2014-004895